CA1189789A - Sterilization process for mammals - Google Patents
Sterilization process for mammalsInfo
- Publication number
- CA1189789A CA1189789A CA000322706A CA322706A CA1189789A CA 1189789 A CA1189789 A CA 1189789A CA 000322706 A CA000322706 A CA 000322706A CA 322706 A CA322706 A CA 322706A CA 1189789 A CA1189789 A CA 1189789A
- Authority
- CA
- Canada
- Prior art keywords
- composition
- mammalian species
- injection
- bacillus
- guerin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 230000001954 sterilising effect Effects 0.000 title claims abstract description 14
- 238000004659 sterilization and disinfection Methods 0.000 title claims abstract description 10
- 238000000034 method Methods 0.000 title abstract description 11
- 241000124008 Mammalia Species 0.000 title abstract description 3
- 230000008569 process Effects 0.000 title abstract description 3
- 241000894007 species Species 0.000 claims abstract description 15
- 238000002347 injection Methods 0.000 claims abstract description 10
- 239000007924 injection Substances 0.000 claims abstract description 10
- 241000193830 Bacillus <bacterium> Species 0.000 claims abstract description 7
- 239000000203 mixture Substances 0.000 claims description 11
- 210000001550 testis Anatomy 0.000 claims description 8
- 241000282472 Canis lupus familiaris Species 0.000 claims description 3
- 241000700198 Cavia Species 0.000 claims description 3
- 241000283973 Oryctolagus cuniculus Species 0.000 claims description 3
- 241000700159 Rattus Species 0.000 claims description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 2
- 239000008365 aqueous carrier Substances 0.000 claims description 2
- 239000011780 sodium chloride Substances 0.000 claims 1
- 239000000725 suspension Substances 0.000 claims 1
- 229940088597 hormone Drugs 0.000 abstract description 2
- 239000005556 hormone Substances 0.000 abstract description 2
- 241001465754 Metazoa Species 0.000 description 5
- 239000003098 androgen Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 230000021595 spermatogenesis Effects 0.000 description 4
- 230000002411 adverse Effects 0.000 description 3
- 229960000190 bacillus calmette–guérin vaccine Drugs 0.000 description 3
- 230000007102 metabolic function Effects 0.000 description 3
- 210000000582 semen Anatomy 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 2
- 241000282693 Cercopithecidae Species 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 206010024870 Loss of libido Diseases 0.000 description 2
- 229940030486 androgens Drugs 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 238000001574 biopsy Methods 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 238000010562 histological examination Methods 0.000 description 2
- 230000003054 hormonal effect Effects 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 230000028993 immune response Effects 0.000 description 2
- 108010082126 Alanine transaminase Proteins 0.000 description 1
- 244000003363 Allium ursinum Species 0.000 description 1
- 241000304886 Bacilli Species 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102000006771 Gonadotropins Human genes 0.000 description 1
- 108010086677 Gonadotropins Proteins 0.000 description 1
- 241000282560 Macaca mulatta Species 0.000 description 1
- 241000288906 Primates Species 0.000 description 1
- 102000007562 Serum Albumin Human genes 0.000 description 1
- 108010071390 Serum Albumin Proteins 0.000 description 1
- 102000005686 Serum Globulins Human genes 0.000 description 1
- 108010045362 Serum Globulins Proteins 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 230000002280 anti-androgenic effect Effects 0.000 description 1
- 230000002365 anti-tubercular Effects 0.000 description 1
- 239000000051 antiandrogen Substances 0.000 description 1
- 229940030495 antiandrogen sex hormone and modulator of the genital system Drugs 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 1
- 229940109239 creatinine Drugs 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000002622 gonadotropin Substances 0.000 description 1
- 229940094892 gonadotropins Drugs 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 210000002332 leydig cell Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 210000000717 sertoli cell Anatomy 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000012414 sterilization procedure Methods 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 208000032922 susceptibility to mycobacterium tuberculosis Diseases 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 238000007879 vasectomy Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA000322706A CA1189789A (en) | 1979-03-02 | 1979-03-02 | Sterilization process for mammals |
| DE2923333A DE2923333C2 (de) | 1979-03-02 | 1979-06-08 | Sterilisierung von Säugern |
| GB7920917A GB2042889B (en) | 1979-03-02 | 1979-06-15 | Sterilizing male mammals with bcg |
| FR7924868A FR2487200A1 (fr) | 1979-03-02 | 1979-10-05 | Composition pour la sterilisation de mammiferes males contenant des bacilles de calmette et guerin |
| IT19567/80A IT1205229B (it) | 1979-03-02 | 1980-01-30 | Processo per la sterilizzazione dei mammiferi |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA000322706A CA1189789A (en) | 1979-03-02 | 1979-03-02 | Sterilization process for mammals |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1189789A true CA1189789A (en) | 1985-07-02 |
Family
ID=4113665
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA000322706A Expired CA1189789A (en) | 1979-03-02 | 1979-03-02 | Sterilization process for mammals |
Country Status (5)
| Country | Link |
|---|---|
| CA (1) | CA1189789A (OSRAM) |
| DE (1) | DE2923333C2 (OSRAM) |
| FR (1) | FR2487200A1 (OSRAM) |
| GB (1) | GB2042889B (OSRAM) |
| IT (1) | IT1205229B (OSRAM) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4720507A (en) * | 1984-03-05 | 1988-01-19 | University Of Western Ontario | Biological contraceptive and contraceptive technique for males |
| US4780312A (en) * | 1985-06-04 | 1988-10-25 | National Institute Of Immunology | Birth control vaccine |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3229234C2 (de) * | 1979-04-13 | 1986-06-19 | Philips Roxane, Inc., St. Joseph, Mo. | Chemische Kastration |
-
1979
- 1979-03-02 CA CA000322706A patent/CA1189789A/en not_active Expired
- 1979-06-08 DE DE2923333A patent/DE2923333C2/de not_active Expired
- 1979-06-15 GB GB7920917A patent/GB2042889B/en not_active Expired
- 1979-10-05 FR FR7924868A patent/FR2487200A1/fr active Granted
-
1980
- 1980-01-30 IT IT19567/80A patent/IT1205229B/it active
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4720507A (en) * | 1984-03-05 | 1988-01-19 | University Of Western Ontario | Biological contraceptive and contraceptive technique for males |
| US4780312A (en) * | 1985-06-04 | 1988-10-25 | National Institute Of Immunology | Birth control vaccine |
Also Published As
| Publication number | Publication date |
|---|---|
| DE2923333A1 (de) | 1980-09-11 |
| GB2042889A (en) | 1980-10-01 |
| IT8019567A0 (it) | 1980-01-30 |
| FR2487200B1 (OSRAM) | 1983-06-24 |
| FR2487200A1 (fr) | 1982-01-29 |
| GB2042889B (en) | 1983-03-09 |
| DE2923333C2 (de) | 1986-07-24 |
| IT1205229B (it) | 1989-03-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Hess et al. | Transfer of an autoimmune nephrosis in the rat by means of lymph node cells | |
| Balner et al. | Testing of anti-human lymphocyte sera in chimpanzees and lower primates | |
| Lisk | A comparison of the effectiveness of intravenous, as opposed to subcutaneous, injection of progesterone for the induction of estrous behavior in the rat | |
| Steblay et al. | Autoimmune glomerulonephritis induced in sheep by injection of human lung and Freund's adjuvant | |
| Vanithakumari et al. | Antifertility effect of Bambusa arundinacea shoot extracts in male rats | |
| Loy et al. | Effects of injected ovarian hormones on the corpus luteum of the estrual cycle in cattle | |
| Milligan et al. | Minimal progesterone support required for the maintenance of pregnancy in mice. | |
| Hoppe | Genetic and endocrine studies of the pregnancy-blocking pheromone of mice | |
| Swift et al. | Experimental Nephritis in Rats Induced by Injection of Anti-Kidney Serum: IV. Prevention of the Injurious Effects of Nephrotoxin in Vivo by Kidney Extract | |
| CA1189789A (en) | Sterilization process for mammals | |
| Pousette et al. | Influence of sex hormones on prostatic secretion protein, a major protein in rat prostate | |
| US4720507A (en) | Biological contraceptive and contraceptive technique for males | |
| Selye | On the protective action of testosterone against the kidney damaging effect of sublimate | |
| Gravis | Ultrastructural observations on spermatozoa retained within the seminiferous epithelium after treatment with dibutyryl cyclic AMP | |
| US4191746A (en) | Sterilization process for mammals | |
| Janes et al. | THE INFLUENCE OF DIETHYL-STILBESTROL ON CARBOHYDRATE METABOLISM IN NORMAL AND CASTRATED RATS | |
| Singer et al. | Secretion of aldosterone and corticosterone by the rat adrenal | |
| Kent Jr | A polypeptide from oviductal contents which influences ovarian function | |
| Casida et al. | Ovarian stimulation by adrenal extracts | |
| Srivastava et al. | Zinc content of maturing spermatozoa in oestrogen treated rats | |
| Smith et al. | Menstrual Discharge of Women. I. Its Toxicity in Rats. | |
| Howell | Effect of sodium Diethyldithiocarbamate on blood copper-levels and pregnancy in the rabbit | |
| Goldman et al. | Induction of infertility in male rats by treatment with gonadotropin antiserum during neonatal life | |
| Rowlands | Selective neutralization of the luteinizing activity of gonadotrophic extracts of pituitary by anti-sera | |
| Woo et al. | Renal and hepatic excretions of phenol red and bromsulphalein in the dog |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKEX | Expiry |